Taken together, CXCL13 and CXCR5 usually act as oncogenic cascades in the promotion of tumor cell survival, proliferation, migration, and invasion, and represent therapeutic targets for the development of novel anti-cancer drugs. The gene discussed is CXCR5; the disease is neoplasm.